Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 488

1.

Increased vein wall thickness in Behçet disease.

Seyahi E, Gjoni M, Durmaz EŞ, Akbaş S, Sut N, Dikici AS, Mihmanli I, Yazici H.

J Vasc Surg Venous Lymphat Disord. 2019 Feb 15. pii: S2213-333X(19)30060-5. doi: 10.1016/j.jvsv.2018.11.006. [Epub ahead of print]

PMID:
30777674
2.

Assessment of deep venous thrombosis in the lower extremity in Behçet's syndrome: MR venography versus Doppler ultrasonography.

Tutar B, Kantarci F, Cakmak OS, Yazici H, Seyahi E.

Intern Emerg Med. 2019 Feb 2. doi: 10.1007/s11739-019-02040-4. [Epub ahead of print]

PMID:
30712149
3.

Faecal but not serum calprotectin levels look promising in predicting active disease in Behçet's syndrome patients with gastrointestinal involvement.

Esatoglu SN, Hatemi I, Ozguler Y, Hatemi G, Uzun H, Celik AF, Yazici H.

Clin Exp Rheumatol. 2018 Nov-Dec;36(6 Suppl 115):90-96. Epub 2018 Dec 13.

4.

The expression levels of miRNA-15a and miRNA-16-1 in circulating tumor cells of patients with diffuse large B-cell lymphoma.

Tuncer SB, Akdeniz D, Celik B, Kilic S, Sukruoglu O, Avsar M, Ozer L, Ekenel M, Ozel S, Yazici H.

Mol Biol Rep. 2018 Dec 14. doi: 10.1007/s11033-018-4554-4. [Epub ahead of print]

PMID:
30552617
5.

Self-assembling antimicrobial peptides on nanotubular titanium surfaces coated with calcium phosphate for local therapy.

Yazici H, Habib G, Boone K, Urgen M, Utku FS, Tamerler C.

Mater Sci Eng C Mater Biol Appl. 2019 Jan 1;94:333-343. doi: 10.1016/j.msec.2018.09.030. Epub 2018 Sep 12.

PMID:
30423715
6.

Editorial: A review of vasculitis 2019: an introduction.

Yazici H, Yazici Y.

Curr Opin Rheumatol. 2019 Jan;31(1):1-2. doi: 10.1097/BOR.0000000000000565. No abstract available.

PMID:
30407227
7.

Management of major organ involvement of Behçet's syndrome: a systematic review for update of the EULAR recommendations.

Ozguler Y, Leccese P, Christensen R, Esatoglu SN, Bang D, Bodaghi B, Çelik AF, Fortune F, Gaudric J, Gul A, Kötter I, Mahr A, Moots RJ, Richter J, Saadoun D, Salvarani C, Scuderi F, Sfikakis PP, Siva A, Stanford M, Tugal-Tutkun I, West R, Yurdakul S, Olivieri I, Yazici H, Hatemi G.

Rheumatology (Oxford). 2018 Dec 1;57(12):2200-2212. doi: 10.1093/rheumatology/key242.

PMID:
30107448
8.

Psammomatoid variant of juvenile ossifying fibroma.

Aslan F, Yazici H, Altun E.

Indian J Pathol Microbiol. 2018 Jul-Sep;61(3):443-445. doi: 10.4103/IJPM.IJPM_577_17.

9.

Single center experience of biotinidase deficiency: 259 patients and six novel mutations.

Canda E, Yazici H, Er E, Kose M, Basol G, Onay H, Ucar SK, Habif S, Ozkinay F, Coker M.

J Pediatr Endocrinol Metab. 2018 Aug 28;31(8):917-926. doi: 10.1515/jpem-2018-0148.

PMID:
29995633
10.

Management of skin, mucosa and joint involvement of Behçet's syndrome: A systematic review for update of the EULAR recommendations for the management of Behçet's syndrome.

Leccese P, Ozguler Y, Christensen R, Esatoglu SN, Bang D, Bodaghi B, Celik AF, Fortune F, Gaudric J, Gül A, Kötter I, Mahr A, Moots RJ, Richter J, Saadoun D, Salvarani C, Scuderi F, Sfikakis PP, Siva A, Stanford M, Tugal-Tutkun I, West R, Yurdakul S, Olivieri I, Yazici H, Hatemi G.

Semin Arthritis Rheum. 2018 May 19. pii: S0049-0172(18)30240-3. doi: 10.1016/j.semarthrit.2018.05.008. [Epub ahead of print]

PMID:
29954598
11.

Assessing the possible association of anti-TNF use with new malignancies: A neglected methodological consideration.

Ozguler Y, Yazici Y, Hatemi G, Tascilar K, Yazici H.

Pharmacoepidemiol Drug Saf. 2018 Aug;27(8):894-901. doi: 10.1002/pds.4579. Epub 2018 Jun 19. No abstract available.

PMID:
29920843
12.

Frequency of Rearrangements Versus Small Indels Mutations in BRCA1 and BRCA2 Genes in Turkish Patients with High Risk Breast and Ovarian Cancer.

Yazıcı H, Kılıç S, Akdeniz D, Şükrüoğlu Ö, Tuncer ŞB, Avşar M, Kuru G, Çelik B, Küçücük S, Saip P.

Eur J Breast Health. 2018 Apr 1;14(2):93-99. doi: 10.5152/ejbh.2017.3799. eCollection 2018 Apr.

13.

Extreme hypercalcemia in a kidney transplant recipient.

Demir E, Karaoglan C, Yegen G, Sair B, Yazici H, Turkmen A, Sever MS.

CEN Case Rep. 2018 Nov;7(2):229-233. doi: 10.1007/s13730-018-0334-1. Epub 2018 Apr 28.

14.

2018 update of the EULAR recommendations for the management of Behçet's syndrome.

Hatemi G, Christensen R, Bang D, Bodaghi B, Celik AF, Fortune F, Gaudric J, Gul A, Kötter I, Leccese P, Mahr A, Moots R, Ozguler Y, Richter J, Saadoun D, Salvarani C, Scuderi F, Sfikakis PP, Siva A, Stanford M, Tugal-Tutkun I, West R, Yurdakul S, Olivieri I, Yazici H.

Ann Rheum Dis. 2018 Jun;77(6):808-818. doi: 10.1136/annrheumdis-2018-213225. Epub 2018 Apr 6.

PMID:
29625968
15.

Behçet syndrome: a contemporary view.

Yazici H, Seyahi E, Hatemi G, Yazici Y.

Nat Rev Rheumatol. 2018 Jan 24;14(2):119. doi: 10.1038/nrrheum.2018.3.

PMID:
29362466
16.

Behçet syndrome: a contemporary view.

Yazici H, Seyahi E, Hatemi G, Yazici Y.

Nat Rev Rheumatol. 2018 Feb;14(2):107-119. doi: 10.1038/nrrheum.2017.208. Epub 2018 Jan 3. Review. Erratum in: Nat Rev Rheumatol. 2018 Jan 24;14 (2):119.

PMID:
29296024
17.

Serum and Urinary Levels of Tumor Necrosis Factor-Alpha in Renal Transplant Patients.

Senturk Ciftci H, Demir E, Savran Karadeniz M, Tefik T, Yazici H, Nane I, Savran Oguz F, Aydin F, Turkmen A.

Exp Clin Transplant. 2018 Dec;16(6):671-675. doi: 10.6002/ect.2017.0166. Epub 2017 Dec 18.

18.

The prevalence of Behçet's disease in the north of Jordan: a hospital-based epidemiological survey.

Madanat WY, Alawneh KM, Smadi MM, Saadeh SS, Omari MM, Bani Hani AB, Yazici H.

Clin Exp Rheumatol. 2017 Nov-Dec;35 Suppl 108(6):51-54. Epub 2017 Nov 27.

PMID:
29224587
19.

Infliximab for uveitis of Behçet's syndrome: a trend for earlier initiation.

Guzelant G, Ucar D, Esatoglu SN, Hatemi G, Ozyazgan Y, Yurdakul S, Seyahi E, Yazici H, Hamuryudan V.

Clin Exp Rheumatol. 2017 Nov-Dec;35 Suppl 108(6):86-89. Epub 2017 Oct 24.

20.

Exacerbation of Behçet's syndrome and familial Mediterranean fever with menstruation.

Guzelant G, Ozguler Y, Esatoglu SN, Karatemiz G, Ozdogan H, Yurdakul S, Yazici H, Seyahi E.

Clin Exp Rheumatol. 2017 Nov-Dec;35 Suppl 108(6):95-99. Epub 2017 Oct 24.

21.

Vasculitis 2018: the bench and the bedside.

Yazici H, Yazici Y.

Curr Opin Rheumatol. 2018 Jan;30(1):1-3. doi: 10.1097/BOR.0000000000000462. No abstract available.

PMID:
29035929
22.

Autologous serum eye-drops and enhanced epithelial healing time after photorefractive keratectomy.

Akcam HT, Unlu M, Karaca EE, Yazici H, Aydin B, Hondur AM.

Clin Exp Optom. 2018 Jan;101(1):34-37. doi: 10.1111/cxo.12574. Epub 2017 Jul 18.

PMID:
28718904
23.

Hypertensive pulmonary edema related to desmopressin acetate.

Korkmaz U, Demir E, Yazici H, Sever MS.

Nefrologia. 2017 May - Jun;37(3):349-350. doi: 10.1016/j.nefro.2016.11.008. English, Spanish. No abstract available.

24.

The liver in familial Mediterranean fever: is it involved?

Ben-Chetrit E, Yazici H.

Clin Exp Rheumatol. 2017 Nov-Dec;35 Suppl 108(6):108-112. Epub 2017 Jun 9. Review.

25.

Two Postmodernisms in Rheumatology.

Yazici H.

Bull Hosp Jt Dis (2013). 2017 Apr;75(2):91-92.

PMID:
28583052
26.

Important Issues Concerning the Double-Blind Study of Anakinra in Familial Mediterranean Fever: Comment on the Article by Ben-Zvi et al.

Yazici H.

Arthritis Rheumatol. 2017 Sep;69(9):1914. doi: 10.1002/art.40167. Epub 2017 Jul 21. No abstract available.

27.

pH-Controlled Cerium Oxide Nanoparticle Inhibition of Both Gram-Positive and Gram-Negative Bacteria Growth.

Alpaslan E, Geilich BM, Yazici H, Webster TJ.

Sci Rep. 2017 Apr 7;7:45859. doi: 10.1038/srep45859.

28.

Developing a Core Set of Outcome Measures for Behçet Disease: Report from OMERACT 2016.

Hatemi G, Meara A, Ozguler Y, Direskeneli H, Mahr A, Easley E, Gurcan M, Davis T, Gul A, Yazici Y, Zottenberg K, Esatoglu SN, Erer B, Kamali S, Yazici H, Cronholm PF, Merkel PA.

J Rheumatol. 2017 Nov;44(11):1750-1753. doi: 10.3899/jrheum.161352. Epub 2017 Apr 1.

PMID:
28365574
29.

A Rare Clinical Entity: Staphylococcus-Related Glomerulonephritis.

Aliyeva N, Demir E, Caliskan Y, Yazici H, Yildiz A.

Exp Clin Transplant. 2017 Mar 28. doi: 10.6002/ect.2016.0066. [Epub ahead of print]

30.

A Novel Biomarker for Post-Transplant Recurrent IgA Nephropathy.

Temurhan S, Akgul SU, Caliskan Y, Artan AS, Kekik C, Yazici H, Demir E, Caliskan B, Turkmen A, Oguz FS, Sever MS.

Transplant Proc. 2017 Apr;49(3):541-545. doi: 10.1016/j.transproceed.2017.02.003.

PMID:
28340830
31.

Influence of Proton Pump Inhibitors on Mycophenolic Acid Pharmacokinetics in Patients With Renal Transplantation and the Relationship With Cytochrome 2C19 Gene Polymorphism.

Ciftci HS, Karadeniz MS, Tefik T, Caliskan Y, Yazıcı H, Demir E, Turkmen A, Nane I, Oguz FS, Aydin F.

Transplant Proc. 2017 Apr;49(3):490-496. doi: 10.1016/j.transproceed.2017.01.029.

PMID:
28340819
32.

Tac-MMF Versus CsA-MMF/CsA-AZA-Based Regimens in Development of De Novo Complement-Binding Anti-HLA Antibodies After Kidney Transplantation.

Sahutoglu T, Akgul SU, Caliskan Y, Yazici H, Demir E, Kara E, Temurhan S, Savran FO, Turkmen A.

Transplant Proc. 2017 Apr;49(3):454-459. doi: 10.1016/j.transproceed.2017.01.005.

PMID:
28340811
33.

Comparison of Two Different Inhalation Anesthetics on Grafted Kidney Function in Patients Undergoing Renal Transplantation Surgery: Desflurane or Sevoflurane?

Karadeniz MS, Ciftci HS, Tefik T, Mammadov O, Yazıcı H, Nane I, Turkmen A, Oguz F, Tugrul KM.

Transplant Proc. 2017 Apr;49(3):448-453. doi: 10.1016/j.transproceed.2017.01.014.

PMID:
28340810
34.

Association Between HLA Antibodies and Different Sensitization Events in Renal Transplant Candidates.

Akgul SU, Ciftci HS, Temurhan S, Caliskan Y, Bayraktar A, Tefik T, Kaya IA, Canitez IO, Demir E, Yazici H, Bakkaloglu H, Aydin AE, Turkmen A, Nane I, Aydin F, Oguz FS.

Transplant Proc. 2017 Apr;49(3):425-429. doi: 10.1016/j.transproceed.2017.02.004.

PMID:
28340805
35.

Susceptiveness of Vitamin K epOxide Reductase Complex Subunit 1 Gene Polymorphism in Essential Hypertension.

Turgut Cosan D, Yazıcı HU, Colak E, Soyocak A, Degirmenci I, Kurt H, Birdane A, Colak E, Gunes HV.

Genet Test Mol Biomarkers. 2017 May;21(5):292-297. doi: 10.1089/gtmb.2016.0311. Epub 2017 Mar 10.

PMID:
28281786
36.

Different Courses of Hepatitis B Reinfection After Renal Transplant: A Case Report.

Yegit O, Demir E, Caliskan Y, Yazici H, Sever MS.

Exp Clin Transplant. 2017 Feb 7. doi: 10.6002/ect.2016.0063. [Epub ahead of print]

37.

Pregnant Woman with Atypical Hemolytic Uremic Syndrome Delivered a Healthy Newborn under Eculizumab Treatment.

Demir E, Yazici H, Ozluk Y, Kilicaslan I, Turkmen A.

Case Rep Nephrol Dial. 2016 Dec 20;6(3):143-148. doi: 10.1159/000454946. eCollection 2016 Sep-Dec.

38.

Behçet syndrome: the vascular cluster.

Yazıcı H, Seyahi E.

Turk J Med Sci. 2016 Nov 17;46(5):1277-1280. doi: 10.3906/sag-1605-28.

PMID:
27966293
39.

An update on vasculitides - lumps and constructs.

Yazici H, Yazici Y.

Curr Opin Rheumatol. 2017 Jan;29(1):1-3. No abstract available.

PMID:
27906751
40.

Missing Information About Disease Controls: Comment on the Article by Mangnus et al.

Esatoglu SN, Seyahi E, Yazici H.

Arthritis Rheumatol. 2017 Mar;69(3):678. doi: 10.1002/art.39980. No abstract available.

41.

Behçet's syndrome in the 2000s: "Where is the wisdom we have lost in knowledge?"

Yazici H.

Clin Exp Rheumatol. 2016 Sep-Oct;34(6 Suppl 102):23-25. Epub 2016 Oct 25. No abstract available.

42.

Bronchial artery enlargement may be the cause of recurrent haemoptysis in Behçet's syndrome patients with pulmonary artery involvement during follow-up.

Esatoglu SN, Seyahi E, Ugurlu S, Gulsen F, Akman C, Cantasdemir M, Numan F, Tuzun H, Melikoglu M, Yazici H, Hamuryudan V.

Clin Exp Rheumatol. 2016 Sep-Oct;34(6 Suppl 102):92-96. Epub 2016 Oct 11.

PMID:
27791952
43.

Effect of colchicine on serum lipid levels.

Ugurlu S, Seyahi E, Hanci I, Pehlevan S, Ozdogan H, Yazici H.

Clin Exp Rheumatol. 2016 Sep-Oct;34(6 Suppl 102):S136. Epub 2016 Feb 9. No abstract available.

PMID:
26885841
44.

Behçet's disease: an MHC-I-opathy?

Hatemi G, Karatemiz G, Yazici H.

Clin Exp Rheumatol. 2017 May-Jun;35 Suppl 104(2):5. Epub 2016 Oct 24. No abstract available.

45.

The effect of histopathologic and clinical features on allograft survival in renal transplant patients with antibody-mediated rejection.

Akagun T, Yazici H, Caliskan Y, Ozluk Y, Sahin S, Turkmen A, Kılıcaslan I, Sever MS.

Ren Fail. 2017 Nov;39(1):19-25. doi: 10.1080/0886022X.2016.1244073. Epub 2016 Oct 24.

46.

Transseptal Subperichondrial Endoscopic Hypophysectomy With Preservation of Vital Nasal Structures.

Yazici H, Doğan S, Sönmez MA, Eser O.

J Craniofac Surg. 2016 Oct;27(7):1834-1836.

PMID:
27763976
47.

Protective Effect of Selenium Against Cisplatin-Induced Ototoxicity in an Experimental Design.

Doğan S, Yazici H, Yalçinkaya E, Erdoğdu HI, Tokgöz SA, Sarici F, Namuslu M, Sarikaya Y.

J Craniofac Surg. 2016 Oct;27(7):e610-e614.

PMID:
27741210
48.

Inadequate reporting of enrolled patient and study site characteristics, and inter-study site differences in randomized controlled trials: A systematic review in six leading medicine journals.

Yurdakul S, Ayan G, Ozguler Y, Hatemi G, Ugurlu S, Seyahi E, Yazici H.

Eur J Intern Med. 2017 Jan;37:e34-e36. doi: 10.1016/j.ejim.2016.09.019. Epub 2016 Oct 5. Review. No abstract available.

PMID:
27720299
49.

Association of paraoxonase 1 (PON1) gene polymorphisms and concentration with essential hypertension.

Turgut Cosan D, Colak E, Saydam F, Yazıcı HU, Degirmenci I, Birdane A, Colak E, Gunes HV.

Clin Exp Hypertens. 2016;38(7):602-607. Epub 2016 Sep 26.

PMID:
27668323
50.

Comparative Analysis of Outcomes of Kidney Transplantation in Patients With AA Amyloidosis and Chronic Glomerulonephritis.

Sahutoglu T, Atay K, Caliskan Y, Kara E, Yazici H, Turkmen A.

Transplant Proc. 2016 Jul-Aug;48(6):2011-6. doi: 10.1016/j.transproceed.2016.04.015.

PMID:
27569937

Supplemental Content

Loading ...
Support Center